Church & Dwight Co Inc

Church & Dwight Co Inc(CHD)股票分析

$105.190

-3.545 (-3.37%)收盤時

Loading chart…
最高
108.485
開盤
107.960
成交量加權均價
106.25
成交量
1.97M
市值
25.43B
最低
105.060
成交金額
208.87M
企業價值/稅息折舊攤銷前利潤(TTM)
19.65

Church & Dwight Co., Inc. is a producer of sodium bicarbonate. It develops, manufactures and markets a range of consumer household and personal care products and specialty products focused on animal nutrition, chemicals and commercial products. Its Consumer Domestic segment includes each of its seven power brands, as well as other brands and household and personal care products. Its Consumer International segment markets a variety of personal care, household and over-the-counter products in international subsidiary markets, including Australia, Canada, France, Germany, Japan, Mexico, China and the United Kingdom. Its Specialty Products Division (SPD) segment focuses on sales to businesses and participates in three product areas: animal nutrition, specialty chemicals and commercial and professional. Its brands include ARM & HAMMER, TROJAN, OXICLEAN, FIRST RESPONSE, NAIR, ORAJEL, XTRA, BATISTE, WATERPIK, ZICAM, THERABREATH, HERO, TOUCHLAND, and Miss Mouth’s Messy Eater, among others.

AI 分析 of Church & Dwight Co Inc (CHD)

買進

Church & Dwight Co Inc is a good buy right now due to its current price of $105.19 being below the analyst price targets, with RBC Capital setting a target of $115 and Deutsche Bank at $112. The company has shown strong financial performance with a gross margin of 46.38% in Q1 2026 and a year-to-date change of +27.29%. However, the main risk is the forward P/E ratio of 23.36, indicating potential overvaluation if growth does not meet expectations.

分析師評級(21)

-6.16% 下跌空間
持有
3 買進
13 持有
5 賣出
目前: 105.19
最低
82.00
平均
98.71
最高
114.00

RBC Capital

2026-08-03

目標價

$115

優於大盤

Deutsche Bank

2026-08-03

目標價

$112

買進

UBS

2026-08-03

目標價

$107

中性

TD Cowen

2026-08-03

目標價

$97

持有

Citi

2026-08-03

目標價

$105

中性

估值指標

Church & Dwight Co Inc(CHD)目前預期本益比為 23.36,5 年平均預期本益比為 27.95。

預期本益比

低估
5 年均值 P/E
27.95
目前P/E
23.36
高估
30.56
低估
25.34

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
18.06
目前EV/EBITDA
19.65
高估
19.73
低估
16.40

預期股價營收比

合理
5 年均值 P/S
3.86
目前P/S
3.97
高估
4.22
低估
3.50

Alphio AI 對 CHD 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CHD

$112.54

情境價格

基

基準

基準 · 50%CHD

$103.23

情境價格

悲

悲觀

悲觀 · 25%CHD

$95.67

情境價格

持有 CHD 的大戶

C

Compass Capital Management Inc.

+ 持有CHD

+7.99%

3個月報酬率

S

Saturna Capital Corporation

+ 持有CHD

+4.41%

3個月報酬率

C

Chesley, Taft & Associates, LLC

+ 持有CHD

+3.39%

3個月報酬率

A

Ampega Investment GmbH

+ 持有CHD

+3.09%

3個月報酬率

F

Fundsmith Investment Services Limited

+ 持有CHD

+2.86%

3個月報酬率

S

S & Co., Inc.

+ 持有CHD

+2.01%

3個月報酬率

CHD 常見問題 —— 由 Alphio AI 解答

Church & Dwight Co., Inc. is a producer of sodium bicarbonate. It develops, manufactures and markets a range of consumer household and personal care products and specialty products focused on animal nutrition, chemicals and commercial products. Its Consumer Domestic segment includes each of its seven power brands, as well as other brands and household and personal care products. Its Consumer International segment markets a variety of personal care, household and over-the-counter products in international subsidiary markets, including Australia, Canada, France, Germany, Japan, Mexico, China and the United Kingdom. Its Specialty Products Division (SPD) segment focuses on sales to businesses and participates in three product areas: animal nutrition, specialty chemicals and commercial and professional. Its brands include ARM & HAMMER, TROJAN, OXICLEAN, FIRST RESPONSE, NAIR, ORAJEL, XTRA, BATISTE, WATERPIK, ZICAM, THERABREATH, HERO, TOUCHLAND, and Miss Mouth’s Messy Eater, among others. It operates in the Consumer Non-Cyclicals sector (SOAP, DETERGENTS, CLEANG PREPARATIONS, PERFUMES, C industry).

Church & Dwight Co Inc is a good buy right now due to its current price of $105.19 being below the analyst price targets, with RBC Capital setting a target of $115 and Deutsche Bank at $112. The company has shown strong financial performance with a gross margin of 46.38% in Q1 2026 and a year-to-date change of +27.29%. However, the main risk is the forward P/E ratio of 23.36, indicating potential overvaluation if growth does not meet expectations.

21 analysts cover CHD: 3 rate it Buy, 13 Hold and 5 Sell. The average price target is 98.71.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易